Private · Company · Aksjeselskap
Arxx Therapeutics AS
815 295 242 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
↳ Brreg · companies
Operating at a lossFY2025 · -4145% margin
Activitylast 24 mo
No job-ad activity on file
totals on file · ads-over-time series not yet in Intelligo
Registry changes
Accounts filed · last_annual_accounts_year2024 → 20252026-08-04
NAV + JobStream · company_hiring · Brreg · company_changes
Timelineall sources
accounts_filed: last_annual_accounts_year2024 -> 2025Registry · 2026-08-04
CALLUNA PHARMA AS acquired 100.0 pctNew owner · 2023-12-31
SARSIA SEED FOND II AS exited (held 17.2 pct)Owner exit · 2023-12-31
P53 INVEST AS exited (held 17.2 pct)Owner exit · 2023-12-31
INVESTINOR INDIREKTE II AS exited (held 7.1 pct)Owner exit · 2023-12-31
ASTEROIDEBAKKEN AS exited (held 7.2 pct)Owner exit · 2023-12-31
RASMUSSENGRUPPEN AS exited (held 14.3 pct)Owner exit · 2023-12-31
TROND MOHN FORSKNINGSSTIFTELSE exited (held 5.1 pct)Owner exit · 2023-12-31
INVESTINOR INDIREKTE II AS acquired 7.1 pctNew owner · 2021-12-31
ASTEROIDEBAKKEN AS acquired 7.2 pctNew owner · 2021-12-31
RASMUSSENGRUPPEN AS acquired 14.3 pctNew owner · 2021-12-31
ASTEROIDEBAKKEN AS exited (held 10.1 pct)Owner exit · 2021-12-31
Skiwo · company_events
Job ads on NAV Arbeidsplassen12 MO
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
LocationOslo
Oslo
municipality only · street address + coordinates not yet in Intelligo
Brreg · registered municipality